1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Approvals

Abbott Launches NeuroSphere Virtual Clinic For Remote Neurostim Programming

 
• By Reed Miller

The US FDA approved Abbott's system that allows physicians to communicate with patients and remotely program their neuromodulation device.

Medicine doctor hand working with modern computer interface as medical network concept

US physicians can now remotely adjust the programming of an Abbott neuromodulation device using the company's new NeuroSphere Virtual Clinic system.

On 8 March, the company announced the US Food and Drug Administration approval and commercial launch of its Virtual Clinic system. According to Abbott, it is the first technology to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation

UK Take Care! Regulatory And Market Access Reforms Must Not Shut Out Medtech Growth

 
• By Ashley Yeo

Speakers at a recent UK medtech outlook conference voiced optimism about the sector’s prospects, but warned that cost burdens, over-regulation and lengthy processes will impede the capacity of local SMEs to innovate. Only 10% of NHS procured medtech comes from UK manufacturers.

Zika Virus Test Among 4 New FDA Device Classifications

 
• By Elizabeth Orr

The FDA plans to announce class II status for four new device types, including tests for the Zika virus and genetic condition Fragile X. This follows earlier announcements and highlights a trend toward diagnostic classifications. The classifications are considered deregulatory, meaning they will hel

FDA Draft Guidance Introduces Electric Submission For Q-Sub Process

 
• By Brian Bossetta

The US FDA says its updated draft guidance represents one of several steps the agency is taking to develop electronic submission templates for the medical device industry. The document introduces stakeholders to currently available resources for supporting their pre-subs to the agency.